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Abstract. Using a specific radioimmunoassay for gonadotropin releasing hormone, the 
presence of gonadotropin releasing hormone like material in the first trimester human 
placenta has been demonstrated. The material has been partially characterized using 
carboxy methyl cellulose chromatography, high pressure gel permeation chromatography 
and reverse phase C18 high pressure liquid chromatographic analysis. Analysis for 
bioactivity revealed that placental gonadotropin releasing hormone is much more active 
than synthetic gonadotropin releasing hormone in in vitro rat pituitary lutinising hormone 
release assay. In vitro biosynthetic studies using labelled precursors and immunoaffinity 
chromatography indicated that first trimester human placenta synthesizes gonadotropin 
releasing hormone like material. 
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Introduction 
The presence of extra hypothalamic gonadotropin releasing hormone (GnRH) like 
material has been reported in placenta (Gibbons et al., 1975; Khodr et al., 1980; 
Nowak et al., 1984), testes (Hedger et al., 1985), ovary (Aten et al., 1986) and 
adrenal cortex (Gautron et al., 1981). Though the precise role of the extra 
hypothalamic GnRH is not well established, it has been suggested that this exerts 
its action locally, as an autocrine system (Hsuesh et al., 1982). Thus several studies 
carriedout using human term placenta have suggested that placental GnRH has an 
important rolein the regulation of chorionic gonadotropin (CG) secretion by 
placenta (Khodr et al.,1978; Siler–Khodr et al., 1986; Rao et al., 1984; Das et al. 
, 1983; Malik et al., 1986). However, it is known that human term placenta is 
minimally active as far as CG production is concerned and placental CG production 
is maximal during the first 6–8 weeks of pregnancy. Thus studies using placenta 
from early stages can be more meaningful and recently we have demonstrated that 
GnRH exerts a differential effect (Rao et al., 1985) on CG production during short 
term incubation of first trimester human placental minces. This observation as well 
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radioimmunoassay; GAP, GnRH associated peptide. 
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as the fact that so far only term human placental GnRH has been well characterized 
(Tan et al., 1982; Seeberg et al., 1984) prompted us to look for the presence and 
biosynthesis of GnRH like material in the first trimester human placenta. 
 
 
 
Materials and methods 
 
Synthetic GnRH was obtained as a gift from Ayerst and Wyeth laboratories, New 
York, USA. The source of various analogues used in the study, the development and 
validation of radioimmunoassay ( RIA) of GnRH used in following the purification of 
placental GnRH have been described in the preceeding paper (Mathialagan et al., 
1986). Antiserum to GnRH raised in goat, used in the immunoaffinity column, was 
generously provided by Dr. H. M. Fraser, MRC Reproductive Biology Unit, 
Edinburgh, UK. Coupling of anti GnRH immunoglobulin G was done according to 
the procedure given by the suppliers (Pharmacia, Sweden). Carboxy methyl 
cellulose (CM cellulose), cyanogen bromide activated sepharose 4B, cycloheximide 
and bovine serum albumin (BSA) were obtained from Sigma Chemicals Co., St. 
Louis, Missouri, USA. [3H]-Leucine (specific activity 100 Ci/mmol)  and [125I]- 
sodium iodide were obtained from Amersham International, England. [I4C]- 
Chlorella hydrolysate (specific activity 20 mCi/m atom C) was supplied by Bhabha 
Atomic Research Centre, Bombay. Eagle's minimum essential medium (EMEM) 
was purchased from Gibco Laboratories, New York, USA. Earle's balanced salt 
solution (EBSS) was obtained from Hi Media, Bombay. Highly purified hCG 
(CR-123,  12,000 IU/mg) used for  iodinat ion was generously provided by 
NIAMDD, USA.All other chemicals used in the study were of analytical grade 
procured from local sources. 
 
Collection of human placenta 
 
Placenta was collected from cases of medical termination of pregnancy (6-
10 weeks) from local hospital. The placenta along with blood was collected in 
EBSS and quickly transported on ice to laboratory. After decanting the blood, 
placenta was extensively washed with EBSS. 
 
Extraction and fractionation of GnRH 
 
Placental villi were minced and processed essentially according to the procedure of 
Guillemin et al. (1963). The minces were homogenized with 2 Ν acetic acid and the 
homogenate was spun at 10,000 g for 20 min at 4°C. The clear supernatant was 
lyophilized (fraction A) and stored at – 20°C until further processing. Fraction A 
was reconstituted (5 mg protein/ml) in distilled water and loaded on CM cellulose 
column (10 × 1·5 cm) equilibrated with 0·01 Μ ammonium acetate, pH 4·5. Flow 
rate was maintained at 8 ml/h to ensure complete retention of GnRH like material 
on to the column. The column was washed extensively with equilibration buffer 
until there was no detectable absorbance at 280 nm, in flow through fractions 
Elution was carried out with 0·1 Μ ammonium acetate, pH 7·5 and 2·0 ml fractions 
were collected. The optical density was monitored at 280 nm and immunoreactivity 
in each fraction was assayed by GnRH specific RIA. The fractions which showed 
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immunoreactivity and eluted at a position corresponding to standard GnRH were 
pooled and lyophilized (fraction B). 
 
 
High pressure liquid chromatographic analysis 
 
High pressure gel permeation chromatography (HP-GPC) of fraction Β was carried 
out on a TSK G2000 SW ultrapac column (LKB, 7·5 × 600 mm, Fr. Range 
0·5-60 K) .  The chromotography system was equipped with two pumps,  a  
solvent programmer attached to UV absorbance detector set at 226 and 280 nm. 
The equilibration buffer was 0·05 Μ phosphate buffer pH 6·8 containing 0·1 Μ 
NaCl. The column was calibrated with standard molecular weight markers (GnRH 
1·1 Κ, ACTH 4·5 Κ, ß-LPH 9·8 Κ, Cyt. C 12·4 K, RNase 13·7 K, trypsin inhibitor 
20 K, ovalbumin 44 Κ  and BSA 65 K). Synthetic GnRH eluted at an elution 
volume of 35 ml and fractions collected were monitored at 226 and 280 nm and also 
for immunoreactivity by GnRH specific RIA. 
Fraction Β was also subjected to reverse phase high pressure liquid chromatogra-
phy (HPLC) analysis using C18 column according to the procedure described 
earlier (Nikolics et al., 1983). The isocratic system used in the analysis consisted of 
58% (v/v) ammonium acetate. 0·05 Μ and 42% (v/v) methanol (pH 4·2). Synthetic 
GnRH had a retention time of 13 min in this system. Gradient elution was carried 
out using the following solvents: (A) 90% (v/v) methanol and 10% (v/v) phosphate 
buffer; 0·1 M, pH 2·0, (B) 10% (v/v) methanol and 90% (v/v) phosphate buffer, 
0·1 M, pH 2·0. In the gradient elution synthetic GnRH eluted with a retention time 
of 22·5 min. 
 
Bioactivity of placental GnRH 
 
The biological activity of placental GnRH was determined using the in vitro rat 
pituitary lutinising hormone (LH) release bioassay as described by Sairam et al. 
(1981). Pituitaries from 20 day old Wistar male rats were incubated at 37°C with 
varying concentrations of GnRH (1-10 ng/ml) in EMEM for 4 h under 95% O2 
and 5% CO2. Medium was separated by centrifugation at 3000 g for 20 min at 4°C 
and analysed for LH by human chorionic gonadotropin (hCG) radioreceptor assay 
as described by Sairam et al. (1981). Iodination of highly purified hCG was done 
according to the method of Greenwood et al. (1963) and the specific activity ranged 
from 40–50 µCi/µg. The assay range was from 0·5-50 ng/tube and minimum 
detectable quantity of rat LH equivalent was 1 ng/tube. The inter and intra assay 
variation of the assay were 12·4% and 9·5%, respectively. 
 
In vitro biosynthesis of GnRH 
 
Placental minces were incubated with 100 μCi of [14C]-chlorella protein hydroly-
sate or [3H]-leucine in the presence of 0·01% bacitracin in 1 ml of EBSS for 2 h at 
37°C under 95% O2 and 5% CO2 in a Dubnoff shaker. Where appropriate,  
cycloheximide was used at a concentration of 500 μΜ. After the incubation, 5 
volumes of 2 Ν acetic acid were added to the incubation flask and the minces were 
homogenized using ground glass homogenizer. The homogenate was centrifuged in 
cold at 10,000 g and the clear supernatant was lyophilized and fractionated on CM 
cellulose column as described earlier. The radioactive fractions which eluted at a 
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position corresponding to that of synthetic GnRH were loaded on a column of anti 
GnRH IgG coupled to cyanogen bromide (CNBr) activated sepharose. Equilibra-
tion and washing of the immunoaffinity column was performed using 0·01 Μ 
phosphate buffer pH 7·4 containing 0·9% (v/v) NaCl. GnRH was eluted from the 
column using 1 Μ acetic acid (Akanxuma et al., 1974). Fractions were monitored 
for radioactivity and absorption at 280 nm. In the experiment where [3H] -leucine 
was used as a precursor approximately 25,000 cpm and in case of [l4C]-chlorella 
hydrolysate, approximately 4,00,000 cpm were loaded on the affinity column. In 
both cases recovery of the radioactivity was 90–95% with about 3% of the 
radioactivity being specifically eluted with 1 Μ acetic acid. 
 
Results 
 
Detection of GnRH like material in placenta by RIA 
 
In order to ascertain the presence of GnRH like material, 2 Ν acetic acid extract 
(fraction A) of the first trimester human placenta was assayed in the GnRH specific 
RIA. It can be seen from the data presented in figure 1 that fraction A gave a dose 
dependent displacement. In acetic acid extraction and CM cellulose chroma-
tography of homogenate caused significant enrichment of placental GnRH like 
activity (table 1). 
 
Figure 1. Standard inhibition plot for GnRH; parallel displacement by fraction A and 
B. 
 
CM cellulose chromatography 
 
The specific elution profile of synthetic GnRH on CM cellulose column is shown in 
figure 2A. This elution profile is characteristic of synthetic GnRH (Guillemin et al., 
1963) and is highly reproducible under standardised conditions. It can be seen that 
following fractionation on CM cellulose column, fraction A gave a peak whose 
elution pattern was exactly similar to that of standard GnRH (fraction B). Analysis 
 of the fractions from this peak for immunoreactivity by GnRH RIA (figures 1 and 
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Table 1. Purification of placental GnRH. 
 
 
Figure 2. Elution profile on CM cellulose column. The column (1·5×7 cm) was 
equilibrated with 0·01 Μ ammonium acetate, pH 4·5. Elution was done with 0·1 Μ 
ammonium acetate, pH 7·5. (A). Synthetic GnRH; (Β). fraction A. 
 
 
 
2) indicated that there is a significant immunoreactivity associated with this peak. It 
should be pointed out that fraction A gave in addition to the peak corresponding to 
GnRH, another peak which did not bind to the column with which considerable 
immunoreactivity is also associated. However, in view of the fact that elution 
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profile of synthetic GnRH is a very characteristic feature, only fraction Β was 
subjected to HPLC analysis. 
 
HPLC analysis 
 
The profile obtained following analysis of fraction Β on HP-GPC is 
shown in figure 3. It can be seen that the fraction Β showed an 
absorption peak (figure 3B) at an elution volume of 35 ml which cor- 
responded well with the immunoreactivity (figure 3C) as well as standard 
elution profile of GnRH (figure 3A). As in the case of CM cellulose analysis, a 
peak of immunoreactivity in the fractions which eluted very early (elution volume 
less than 8 ml) was noticeable. The results of analysis of fraction Β on reverse phase 
C18 (RP C18) column using isocratic system and gradient elution are shown in 
figures 4 and 5, respectively. It can be seen that in the isocratic system, a clear peak 
corresponding exactly to the retention time 13 min of standard GnRH was 
observed. In the case of gradient elution (figure 5) a peak corresponding to the 
retention time 22·5 min of standard GnRH was noticed and it can also be seen that 
the peak heights were concentration dependent. All these results together strongly 
 
Figure 3. HPGPC analysis of fraction B. See methods for details of column and buffer 
used. Elution profile of (A) standard GnRH, (Β) and (C) fraction B. 
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Figure 4.  RP C18 HPLC analysis: Isocratic system. 
 
support the conclusion that there is a material which is very similar to hypothalamic 
GnRH in the f irs t  t r imester  human placenta.  
 
Biological activity of placental GnRH 
 
The results presented in figure 6A show that following addition of 1-10 ng of 
synthetic GnRH there was a significant, dose dependent increase in the hCG equi- 
valent of rat LH released into the medium, thus validating the radioreceptor assay. 
The results of the effect of addition of fraction A and fraction Β on the release of 
LH into the medium is shown in figure 6B. It can be seen that both fractions 
showed significant, dose dependent stimulation. Interestingly both fractions 
exhibited much higher activity than standard GnRH. The highest quantity of 
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Figure 5. RP C18 HPLC analysis: Gradient elution. 
 
 
fraction A and Β tested corresponded to 0·5 ng and 0·25 ng of immunoreactive 
GnRH and at these concentrations, they were 3 and 4 fold more active respectively 
than synthetic GnRH used in the study. 
 
In vitro biosynthesis of placental GnRH 
 
Biosynthesis of placental GnRH was monitored by following the incorporation of 
[3H]-leucine or [l4C]-chlorella hydrolysate into 2 Ν acetic acid extractable peptides 
which were fractionated on CM cellulose column. The results of this study are 
presented in figure 7. It is clear that the incorporation of both [14C] and [3H] 
radioactivity corresponding to the elution of standard GnRH on CM cellulose 
column could be observed. Analysis by specific RIA indicate that immunoreactivity 
is also associated with the radioactivity peak suggesting that the peak represents the 
newlysynthesized GnRH. Experiments carried out in presence of cycloheximide 
(500 μm) indicate that the synthesis of GnRH is dependent upon protein synthesis 
as there is a considerable decrease in the incorporation of labelled precursor into 
this fraction (figure 8). 
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Figure 6. Bioactivity of placental GnRH. (A). Dose response with synthetic GnRH 
Quantity (ng) of GnRH added per tube indicated in parenthesis. (B) Bioactivity of (1) 
synthetic GnRH (l0 ng/tube) ; (2), fraction A ; (3), fraction Β , Figures in the 
parenthesis indicate the quantities (ng/tube) of immunoassayable GnRH added. Each 
point presents Mean ± SEM of triplicate determinations. 
 
To further establish the identity of the radioactive peak corresponding to GnRH. 
this material was applied to GnRH immunoaffinity column and the results are 
presented in figure 9. It can be seen that in both experiments where [3H]-leucine or 
[14C]-chlorella hydrolysate was used as a precursor, a peak of radioactivity which 
corresponded to the elution profile of standard GnRH was noticeable, though the 
specific radioactivity recovered in the fraction was only about 3% of the total 
radioactivity applied to the column. 
 
Discussion 
 
The presence of GnRH like material in extrahypothalamic sources has been 
reported using immunochemical methods or the conventional isolation procedures 
or a combination of both (Khodr et al., 1980; Gautron et al., 1981; Tan et al., 1982; 
Hedger et al., 1985). We have been able to conclusively demonstrate the presence 
of GnRH like material in human placenta using a combination of immunological, 
biochemical and biosynthetic approaches. The RIA employed in the study has been 
validated for its specificity (Mathialagan et al., 1986). As mentioned earlier the 
elution profile of hypothalamic GnRH on CM cellulose column was characteristic 
and we have successfully employed this in following the purification of placental 
GnRH. The purification achieved at various steps is also a clear indication that we 
have purified a GnRH like material. HPLC analysis provided an additional 
evidence for the identity of a placental GnRH like peptide. Most importantly the 
material isolated from placenta had biological activity similar to that of GnRH in 
the in vitro rat pituitary assay. We have also consistently observed that placental 
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Figure 7. In vitro biosynthesis of placental GnRH: Elution profile on CM cellulose 
column of 2 Ν acetic acid extractable peptides. (A), [14C]-chlorella hydrolysate; (B), 
[3Ή]-leucine. 
 
GnRH like material was found to be more active than synthetic GnRH in the 
bioassay and interestingly a similar observation has been made by Siler-Khodr et 
al. (1986). However, as the material has not been purified to homogenity, it is 
possible that the placental material may have in addition to native GnRH other 
materials which possess GnRH like activities. This conclusion is supported by the 
fact that HP-GPC analysis reveals multiple immunoreactive peaks in addition to 
the peak corresponding to standard GnRH (figure 3C). Recently Nowak et al. 
(1984) have suggested that the presence of significant part of GnRH like activity is 
due to factors other than GnRH in rabbit placenta. 
It is known that the proteolysis of GnRH in tissues occurs between Gly6-Leu7 
bond (Koch et al., 1974) and the half life of GnRH is extremely low (Elkind-Hirsch 
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Figure 8. In vitro biosynthesis of placental GnRH: Effect of cycloheximide, 500 μΜ 
(Ο, ● ). 
 
 
et al., 1982). Thus use of [3H]-leucine alone as a precursor in in vitro biosynthetic 
studies of GnRH will result in a decreased incorporation of label. In order to 
eliminate this uncertainty we have employed [l4C]-chlorella protein hydrolysate 
also as a precursor. Studies using immunoaffinity chromatography also support the 
conclusion that GnRH is biosynthesized in the first trimester human placenta. The 
immunological identity of the synthesized GnRH is further established by the fact 
that we have employed a rabbit antiserum to GnRH in RIA and a goat antiserum to 
GnRH for immunoaffinity chromatography. The foregoing results establish that 
placental GnRH also has similar immunological and biological characteristics of the 
hypothalamic counterpart. 
During the course of CM cellulose analysis of fraction A we have consistently 
observed a peak of immunoreactive material in the flow through fractions. At the 
moment we are not clear as to the identity of this fraction. It may be pertinent to 
point out that post translational processing of the precursor of GnRH results into 
two peptide fragments (Nikolics et al., 1985), one of which is a 56 amino acid 
C-terminal peptide (GnRH-associated peptide, GAP) having a prolactin release 
inhibiting activity as well as gonadotropin releasing activity in pituitary cell 
cultures. It may be possible that the immunoreactive CM cellulose flow through 
fraction represents the GAP peptide. Additional information as to the immunolo- 
gical reactivity of GAP with GnRH antiserum and its chromatographic fractiona- 
tion will be of help in establishing the identity of the CM cellulose column flow 
through peptide observed in our studies. 
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Figure 9. In vitro biosynthesis of placental GnRH: Immunoaffinity chromatographic 
analysis of fraction B. (A), Standard GnRH; (Β), [14C]-labelled fraction Β; (C), 
 [3H]-labelled fraction B. 
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